# US 2020/0268276 A1 · Methods and apparatus for guiding medical care based on detected gastric function

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0268276 A1
- Document ID: US20200268276A1
- Status: Published application
- Kind: A1
- Application number: 16/870,014
- Filed: 2020-05-08
- Published: 2020-08-27
- Earliest claimed: 2011-06-14
- Assignees: Gravitas Medical, Inc.
- Applicants: Gravitas Medical, Inc.
- Inventors: Elliott BENNETT-GUERRERO
- Web page: https://patentgrep.com/patent/US20200268276A1

## CPC

- A61B 5/0538: invasively, e.g. using a catheter
- A61B 5/073: {Intestinal transmitters}
- A61B 5/14503: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors (A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence)}
- A61B 5/14507: {specially adapted for measuring characteristics of body fluids other than blood (devices for taking samples of body liquids A61B10/0045)}
- A61B 5/14539: {for measuring pH}
- A61B 5/4238: {stomach}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/7445: {Display arrangements, e.g. multiple display units}
- A61J 15/0084: {for sensing parameters related to the patient}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 31/341: not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 38/08: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61B 2010/0061: {Alimentary tract secretions, e.g. biliary, gastric, intestinal, pancreatic secretions}
- A61J 15/0003: {Nasal or oral feeding-tubes, e.g. tube entering body through nose or mouth}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.

## Claims

### Claim 1

A device for insertion into a stomach of a patient for use with enteral feeding, comprising:
an indwelling tube having a length;
one or more impedance sensors attached along the length of the indwelling tube, wherein the one or more impedance sensors are configured to detect an electrical property of gastric contents;
a controller in communication with the one or more impedance sensors, wherein the controller is configured to determine measurements of a volume of gastric contents by correlating the electrical property of gastric contents to the volume of gastric contents such that the measurements of the volume of gastric contents provide guidance via the controller for patient care.

### Claim 2 (depends on 1)

The device of claim 1 wherein the one or more impedance sensors are attached along the length at a position such that the sensors are placed within the stomach when the indwelling tube is inserted into the patient.

### Claim 3 (depends on 1)

The device of claim 1 wherein the one or more impedance sensors are attached along the length at a position such that the sensors are placed distal to a pylorus of the stomach when the indwelling tube is inserted into the patient.

### Claim 4 (depends on 1)

The device of claim 1 wherein the guidance for patient care comprises instructions provided via the controller to perform at least one of initiation, maintenance, increase, reduction, or termination of enteral feeding via the controller.

### Claim 5 (depends on 4)

The device of claim 4 wherein the controller comprises a processor configured to provide the instructions.

### Claim 6 (depends on 1)

The device of claim 1 wherein an intensity of treatment of the patient care is determined as a function of the measurements.

### Claim 7 (depends on 1)

The device of claim 1 wherein the guidance for patient care comprises a nutritional readiness score determined from the measurements of the gastric volume.

### Claim 8 (depends on 1)

The device of claim 1 wherein the guidance for patient care provided via the controller comprises a determination of initiating, terminating, or weaning enteral feeding via the controller.

### Claim 9 (depends on 1)

The device of claim 1 wherein the guidance for patient care provided via the controller comprises a determination of modifying vasoactive agents, mechanical ventilation, acid suppressants, or motility agents via the controller.

### Claim 10 (depends on 1)

The device of claim 1 wherein the controller is configured to provide the measurements on a continuous basis.

### Claim 11 (depends on 1)

The device of claim 1 wherein the device is configured to measure a presence and passage of a stress agent configured to affect the measurement of the gastric volume.

### Claim 12 (depends on 11)

The device of claim 11 wherein the stress agent comprises a bolus of food.

### Claim 13 (depends on 11)

The device of claim 11 wherein the bolus of food comprises liquid food.

### Claim 14 (depends on 11)

The device of claim 11 wherein the controller is configured to determine the gastric volume after the stress agent is provided to the patient.

### Claim 15 (depends on 1)

The device of claim 1 wherein the controller is programmed to provide the guidance for patient care via the controller based on the measurements of the gastric volume.

### Claim 16 (depends on 15)

The device of claim 15 wherein the controller is programmed to compare the measurements of gastric volume against aggregate measurements provided by the controller of gastric volume obtained from other patients having profile data correlated to the patient.

### Claim 17 (depends on 16)

The device of claim 16 wherein the profile data comprises at least one of age, gender, fitness, weight, body composition, percentage of body fat, ethnicity, family history, personal medical history, and genetics.

### Claim 18 (depends on 15)

The device of claim 15 wherein the controller is programmed to calculate a rate of change of the measurements of gastric volume.

### Claim 19 (depends on 1)

The device of claim 1 wherein the one or more impedance sensors are configured to provide an indication of tube placement within the patient.

### Claim 20 (depends on 1)

The device of claim 1 wherein the one or more impedance sensors are configured to provide an indication of gastric motility.

### Claim 21 (depends on 1)

The device of claim 1 wherein the device is configured to measure the presence and passage of a gastric acid suppressant configured to affect the measurement of the gastric volume.
